JP2021518438A5 - - Google Patents

Info

Publication number
JP2021518438A5
JP2021518438A5 JP2021500350A JP2021500350A JP2021518438A5 JP 2021518438 A5 JP2021518438 A5 JP 2021518438A5 JP 2021500350 A JP2021500350 A JP 2021500350A JP 2021500350 A JP2021500350 A JP 2021500350A JP 2021518438 A5 JP2021518438 A5 JP 2021518438A5
Authority
JP
Japan
Prior art keywords
composition according
composition
silodosin
azoospermia
amount
Prior art date
Application number
JP2021500350A
Other languages
English (en)
Japanese (ja)
Other versions
JP7270901B2 (ja
JPWO2019180217A5 (https=
JP2021518438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/057267 external-priority patent/WO2019180217A1/en
Publication of JP2021518438A publication Critical patent/JP2021518438A/ja
Publication of JPWO2019180217A5 publication Critical patent/JPWO2019180217A5/ja
Publication of JP2021518438A5 publication Critical patent/JP2021518438A5/ja
Application granted granted Critical
Publication of JP7270901B2 publication Critical patent/JP7270901B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021500350A 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法 Active JP7270901B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328.9 2018-03-23
EP18305328 2018-03-23
US62/763,129 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (4)

Publication Number Publication Date
JP2021518438A JP2021518438A (ja) 2021-08-02
JPWO2019180217A5 JPWO2019180217A5 (https=) 2022-03-30
JP2021518438A5 true JP2021518438A5 (https=) 2022-03-30
JP7270901B2 JP7270901B2 (ja) 2023-05-11

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500350A Active JP7270901B2 (ja) 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法

Country Status (19)

Country Link
US (3) US10912762B2 (https=)
EP (2) EP3562485B8 (https=)
JP (1) JP7270901B2 (https=)
KR (1) KR102496504B1 (https=)
CN (1) CN112074269A (https=)
AU (1) AU2019237228B2 (https=)
BR (1) BR112020018925A2 (https=)
CA (1) CA3094016C (https=)
DK (2) DK3750538T3 (https=)
ES (2) ES2989170T3 (https=)
FI (1) FI3750538T3 (https=)
IL (1) IL277372B2 (https=)
MA (1) MA53626B1 (https=)
MX (1) MX2020009937A (https=)
PL (2) PL3750538T3 (https=)
PT (1) PT3562485T (https=)
SG (1) SG11202008794TA (https=)
UA (1) UA128502C2 (https=)
WO (1) WO2019180217A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę
AU2023384256A1 (en) * 2022-11-23 2025-03-20 Pharmajor Incorporated Modified-release silodosin compositions and use thereof in methods for male contraception

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
HUP0300128A3 (en) 2000-02-15 2004-03-29 Schering Ag Male contraceptive composition comprising norethisterone and its use
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
MX2009003737A (es) * 2006-10-05 2009-06-16 Panacea Biotec Ltd Composicion inyectable en deposito y su procedimiento de preparacion.
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
JPWO2016051782A1 (ja) 2014-09-30 2017-07-13 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
PL3750538T3 (pl) * 2018-03-23 2024-11-25 Pharmajor International Niehormonalne sposoby męskiej antykoncepcji obejmujące (r) -sylodosynę

Similar Documents

Publication Publication Date Title
JP2005512995A5 (https=)
JP2013530220A (ja) ダポキセチンを含む時間差徐放性経口投与型の薬学的組成物
JP2016504384A5 (https=)
JP2013529665A5 (https=)
JP2009536176A5 (https=)
CN104684553A (zh) 治疗多发性硬化症的组合疗法
JP2008543936A5 (https=)
JP2021088575A5 (https=)
RU2009102443A (ru) Фармацевтический препарат для контрацепции и для предотвращения риска врожденных пороков развития
JP2021502382A5 (https=)
JP2021518438A5 (https=)
IL272834B1 (en) Compositions of amantadine, their preparation, and methods of use
JP2020536931A (ja) 二層医薬錠剤製剤
KR20200014289A (ko) 우울증을 치료하기 위한 조성물 및 방법
ES2989170T3 (es) Métodos no hormonales para la anticoncepción masculina que comprenden (R)-silodosina
JPWO2019180217A5 (https=)
US12186325B2 (en) Treatment and prevention of premature ejaculation (PE)
JP4695326B2 (ja) 鼻炎用医薬組成物
NZ767741B2 (en) Non-hormonal compositions and methods for male contraception
JP2009235093A (ja) 鼻炎用医薬組成物
JP2024084670A5 (https=)
HK40053063A (en) Treatment and prevention of premature ejaculation (pe)
HK40053063B (en) Treatment and prevention of premature ejaculation (pe)
WO2014048511A1 (en) Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
RU2020119035A (ru) Композиции рифамицина sv для перорального применения